{"id":"W2492745064","doi":"10.1038/bmt.2016.188","title":"A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation","year":2016,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Otsuka Pharmaceutical","keywords":"Medicine; Busulfan; Clofarabine; Hematopoietic stem cell transplantation; Transplantation; Stem cell; Internal medicine; Oncology; Surgery; Hematopoietic cell; Haematopoiesis; Chemotherapy; Cytarabine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006620958,0.0001859915,0.0004250711,0.0002226907,0.00008410769,0.000006998577,0.00006676344,0.0001901585,0.00009154684],"category_scores_gemma":[0.00003864552,0.0001116196,0.00009102372,0.0002055,0.0001653334,0.0001966102,0.000009986592,0.0001453265,0.000005060257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00022735,"about_ca_system_score_gemma":0.0001723967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002991659,"about_ca_topic_score_gemma":0.00006995865,"domain_scores_codex":[0.998151,0.0002116629,0.0006915656,0.0003290377,0.0003903256,0.0002264118],"domain_scores_gemma":[0.9985497,0.0007186552,0.0003126349,0.0001887635,0.0001583253,0.00007193797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1334941,0.0001287041,0.000783902,0.001653911,0.00004209495,0.00002263784,0.003517993,0.00001602893,0.8566007,0.00001745124,0.0000915726,0.003630858],"study_design_scores_gemma":[0.1146524,0.001677171,0.02866299,0.001462252,0.0004611301,0.0002066564,0.00046518,0.000259751,0.8518289,0.00004586298,0.00006843235,0.0002092459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992609,0.00005519691,0.002810445,0.001680689,0.0000510527,0.002404576,0.0002685913,0.00002082416,0.00009957497],"genre_scores_gemma":[0.996266,0.0006493511,0.0009844359,0.00005891263,0.00004480148,0.0001578003,0.000516443,0.00003185207,0.001290387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02787908,"threshold_uncertainty_score":0.4551714,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01770462474023073,"score_gpt":0.2645491263480593,"score_spread":0.2468445016078286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}